awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q52641603-3C1DF794-7CB2-4E20-963C-D7940D1441CB
Q52641603-3C1DF794-7CB2-4E20-963C-D7940D1441CB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52641603-3C1DF794-7CB2-4E20-963C-D7940D1441CB
New therapeutics to treat castrate-resistant prostate cancer.
P2860
Q52641603-3C1DF794-7CB2-4E20-963C-D7940D1441CB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52641603-3C1DF794-7CB2-4E20-963C-D7940D1441CB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
173192973066bd1e5cf25beea9a18e1ec53fa0ab
P2860
Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.